Key result
The National Institute on Drug Abuse has identified ten high-priority pharmacological mechanisms for the rapid development of novel therapeutics to treat opioid overdose and opioid use disorder.
NIDA has established a prioritized list of ten pharmacological mechanisms to guide and accelerate the development of new medications for opioid use disorder and overdose.
The United States is in the midst of a horrific problem. The rampant misuse of opioid drugs (both prescribed and illegal), now known as the Opioid Crisis, has had grave effects on both the public health and the well-being of our society. In 1 year, 2017, it is estimated that almost as many Americans died from opioid-related overdose as died in the entire Vietnam War [ 1 ]. In response to the problem, the White House has declared the Opioid Crisis a national Public Health Emergency under federal law [ 2 ].
No takes yet. Share an insight, caveat, or question.
Rasmussen et al. (2018) conducted an editorial in Opioid Use Disorder and opioid overdose. Novel pharmacotherapies for Opioid Use Disorder was evaluated. The National Institute on Drug Abuse has identified ten high-priority pharmacological mechanisms for the rapid development of novel therapeutics to treat opioid overdose and opioid use disorder.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: